To further explore the therapeutic value of MARCKSL1 in cancer treatment, data from drug sensitivity analyses were collected using the NCI-60 cell line panel and RNA sequencing data from cell lines in the National Cancer Institute (NCI) database. Here, MARCKSL1 is linked to cancer.